Tyree Dangelo Partners
Tyree & D’Angelo Partners describes a lower-middle-market private equity strategy built around control investments, owner and management partnerships, and add-on acquisition opportunities.
What stands out about Tyree Dangelo Partners
TDP states that it targets companies with less than $50 million of annual revenue and $1–$5 million of annual EBITDA, with a bias toward healthcare, consumer, and business services and no minimum financial requirement for add-on acquisitions.[1][2][3][10][11]
What does Tyree Dangelo Partners invest in?
Tyree & D’Angelo Partners (TDP) is the private equity firm presented on tdpfund.com. It describes its approach as buying and building high-quality businesses through partnerships with owners and executives.
TDP focuses on lower-middle-market companies and describes control ownership investments, management and business-owner co-investment, aligned transaction structures, and conservative financing as elements of its transaction approach.[1][2]
TDP states that it employs a disciplined buy-and-build strategy focused on lower-middle-market companies, proactive investment thesis development, and value-creation-plan development.
Its stated strategy also emphasizes fragmented markets with add-on acquisition opportunities. The firm describes its transactions as involving control ownership, co-investment from management and business owners, aligned structures, and conservative financing.[2]
Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.
What should a business owner evaluate before considering a transaction with Tyree Dangelo Partners?
Owners evaluating TDP may want to clarify how a proposed control ownership investment would address management and business-owner co-investment, aligned transaction structures, and shared economic ownership. TDP’s partnering page states that it works collaboratively with executives and business owners in a trusted environment while sharing significant economic ownership.
The stated buy-and-build strategy also makes the proposed value-creation plan, add-on acquisition approach, financing structure, governance arrangements, and management economics important areas for transaction diligence. The public transaction examples are selected announcements rather than a complete disclosure of current portfolio companies or transaction economics.[2][3][10][11]
What percentage of equity and voting control would TDP seek, and what co-investment would be expected from selling owners or management
What value-creation plan and add-on acquisition strategy would apply to the company
What companies does Tyree Dangelo Partners target?
TDP seeks differentiated companies with sustainable value propositions, strong management teams interested in a true partnership, and the ability to add significant value.
It also identifies stable to positive underlying demand trends and fragmented sectors with substantial add-on acquisition opportunities as criteria. TDP states that it targets companies with less than $50 million of annual revenue and $1–$5 million of annual EBITDA.[2]
TDP states a bias toward healthcare, consumer, and business services sectors. Its public examples include veterinary support organizations and dental support organizations.[2]
TDP states that it focuses on stable or growing industries in the U.S. and Canada.[2]
TDP’s stated strategy distinguishes between lower-middle-market company targets and add-on acquisitions. Its criteria for primary company targets include revenue and EBITDA parameters, while TDP states that add-on acquisitions have no minimum financial requirement.
The firm also identifies fragmented sectors and substantial add-on acquisition opportunities as part of its company criteria.[2]
The official Investments page cited for this profile does not identify the companies in TDP’s investment portfolio. Selected official transaction announcements provide examples involving Western Veterinary Partners, Signature Dental Partners, Heartland Veterinary Partners, and Elite Dental Partners, but they do not establish a complete current portfolio.[4][5][6][7][10][11]
On November 3, 2025, TDP announced that it closed a single-asset secondary transaction forming a continuation fund for Western Veterinary Partners, with new capital to support ongoing growth and acquisitions.
On October 17, 2022, TDP announced a strategic minority investment in Signature Dental Partners by Mitsui & Co.; the announcement identified TDP as Signature Dental Partners’ private equity sponsor and control investor.
On December 12, 2019, TDP announced a majority recapitalization of Heartland Veterinary Partners with Gryphon Investors investing alongside TDP and management. On June 12, 2018, TDP announced a majority recapitalization of Elite Dental Partners with Cressey & Company investing alongside TDP and management.[4][5][6][7]
What is not clear from Tyree Dangelo Partners's public investment criteria?
The official Investments page cited for this profile does not identify the companies in TDP’s investment portfolio, transaction dates, valuation amounts, buyer identities, financing terms, or consideration terms.
The official News page cited for this profile lists selected announcements but does not present a complete current portfolio or complete transaction-level economics for the listed announcements.[10][11]
Questions to ask when evaluating Tyree Dangelo Partners as a buyer or investment partner
What percentage of equity and voting control would TDP seek, and what co-investment would be expected from selling owners or management?
What value-creation plan and add-on acquisition strategy would apply to the company?
How would management economics, governance rights, distributions, and other aligned transaction structures be defined?
What financing structure and leverage constraints would apply to the proposed transaction?
Which current portfolio companies, executives, or selected transaction participants could serve as relevant references?
Sources & research notes
- Official website / firm overview
- Investment strategy
- Investment approach
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Structure / regulatory context
- SEC filing / regulatory record
- Public disclosure information
- Public disclosure information
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.